Table 3 Association between commonly reported symptoms, and positivity of the SARS-CoV-2 RT-PCR test (unadjusted and adjusted analysis).
From: Cross sectional study of the clinical characteristics of French primary care patients with COVID-19
Symptoms | Crude OR (95% CI) | p-value1 | Adjusted OR (95%CI)2 | Adjusted p-value3 |
|---|---|---|---|---|
ENT symptoms | ||||
Dry throat (n = 1476) | 1.0 (0.9–1.2) | 0.76 | 0.9 (0.6–1.2) | 0.41 |
Dry nose (n = 1475) | 1.6 (1.6–1.6) | < 0.001 | 1.3 (1.1–1.6) | 0.01 |
Sore throat (n = 1517) | 0.5 (0.4–0.7) | < 0.001 | 0.6 (0.4–0.8) | 0.003 |
Stuffy nose (n = 1477) | 0.6 (0.4–0.9) | 0.02 | 0.6 (0.6–0.7) | < 0.001 |
Loss of taste (n = 1543) | 7.8 (6.2–9.9) | < 0.001 | 3.8 (3.3–4.4) | < 0.001 |
Loss of smell (n = 1543) | 7.4 (5.8–9.4) | < 0.001 | 3.0 (1.9–4.8) | < 0.001 |
Loss of taste and smell (n = 1543) | 8.5 (4.3–16.7) | < 0.001 | 6.5 (3.9–10.8) | < 0.001 |
Loss of taste or smell (n = 1543) | 8.0 (7.2–8.8) | < 0.001 | 6.7 (5.9–7.5) | < 0.001 |
Other symptoms | ||||
Chest pain (n = 1478) | 0.8 (0.7–0.8) | < 0.001 | 0.9 (0.7–1.1) | 0.32 |
Fever (n = 1497) | 1.7 (1.0–2.8) | 0.04 | 2.1 (0.7–5.9) | 0.18 |
Fatigue (n = 1517) | 0.7 (0.5–1.0) | 0.08 | 0.7 (0.4–1.1) | 0.11 |
Headache (n = 1487) | 0.7 (0.6–0.9) | < 0.001 | 1.0 (1.0–1.1) | 0.46 |
Cough (n = 1517) | 1.3 (0.8–2.3) | 0.27 | 1.0 (0.7–1.3) | 0.81 |
Muscle pain (n = 1517) | 1.8 (1.3–2.5) | 0.001 | 1.6 (1.2–2.0) | 0.001 |
Dyspnea (n = 1517) | 0.5 (0.4–0.8) | < 0.001 | 0.5 (0.3–0.7) | < 0.001 |
Diarrhea (n = 1480) | 0.6 (0.3–1.0) | 0.04 | 0.6 (0.5–0.6) | < 0.001 |
